高级检索
当前位置: 首页 > 详情页

HLA-E inhibitor enhances the killing of neuroblastoma stem cells by co-cultured dendritic cells and cytokine-induced killer cells loaded with membrane-based microparticles

| 认领 | 导出 |

文献详情

资源类型:
机构: [1]State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [3]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou, Guangdong, Peoples R China; [4]Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [5]Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China
出处:
ISSN:

关键词: Neuroblastoma stem cell immunotherapy human leukocyte antigen monoclonal antibody

摘要:
Neuroblastoma stem cells (NSCs) can cause drug resistance and tumor recurrence. This study aimed to enhance the lytic effect of dendritic cells (DCs) co-cultured with cytokine-induced killer (CIK) cells. NSCs were obtained by suspension culture, and DC-CIK cells were loaded with extracted NSC membrane-based microparticles (MMPs) before evaluating the lytic effect of DC-CIK cells on NSCs. After inhibiting the function or expression of human leukocyte antigen-E (HLA-E) in NSCs by anti-HLA-E monoclonal antibody or siRNA, the DC-CIK cell lytic effect on NSCs was re-assessed. NSC nestin expression was high, but glial fibrillary acid protein expression and class III beta-tubulin-1 expression were low. Moreover, NSCs exhibited strong tumorigenic ability in nude mice. Loading DCs with NSC-derived MMPs induced the differentiation of DCs and CIK cells and enhanced the killing of NSCs by DC-CIK cells. Inhibiting the function or expression of HLA-E in NSCs further enhanced the cytolytic capability of DC-CIK cells loaded with NSC-derived MMPs. HLA-E inhibitor can enhance the killing of NSC by DC-CIK cells loaded with NSC-derived MMPs.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
第一作者:
第一作者机构: [1]State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [4]Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China;
通讯作者:
通讯机构: [1]State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [2]Sun Yat Sen Univ, Ctr Canc, Dept Pediat Oncol, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China; [4]Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43376 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号